P00517 (KAPCA_BOVIN) Bos taurus (Bovine)

cAMP-dependent protein kinase catalytic subunit alpha UniProtKBInterProSTRINGInteractive Modelling

351 aa; Sequence (Fasta) ; 4 identical sequences: Bos indicus: A0A6P5C1U0; Moschus moschiferus: A0A8C6D5M4; Bos indicus x Bos taurus: A0A4W2GDJ9; Bos mutus grunniens: A0A8B9YI28

Available Structures

90 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Protein kinase A variant complex with completely ordered N-terminal helix
1smh
 Heteromer
P61926; 		2-351
6×BU3; 1×MG8;
Assess
Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu…
1xha
 Heteromer
P61925; 		2-351
1×R68;
Assess
The Catalytic Subunit of cAMP-dependent Protein Kinase in Complex with Rho-kinase Inhibitor H-1152P
1q8u
 Heteromer
P63249; 		8-351
2×H52; 1×MG8;
Assess
The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors
3zo2
 Heteromer
Q3SX13; 		8-351
1×15I; 2×GOL; 1×MPD;
Assess
Crystal structures of the kinase domain of PKA in complex with ATP-competitive inhibitors
3e8e
 Heteromer
Q3SX13; 		8-351
1×G98;
Assess
Crystal structures of the kinase domain of PKA in complex with ATP-competitive inhibitors
3e8c
 Heteromer
Q3SX13; 		8-351
1×G96;
Assess
Crystal Structure of Protein Kinase A in Complex with Azepane Derivative 1
1sve
 Heteromer
P61926; 		8-351
1×NA; 1×I01; 1×MG8;
Assess
Structure of PKA-PKB chimera complexed with C-(4-(4-Chlorophenyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-y…
2vo0
 Heteromer
P61925; 		9-351
1×CL; 1×MRD; 2×EDO; 2×M03;
Assess
The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors
3zo1
 Heteromer
Q3SX13; 		10-351
1×SIJ; 4×GOL; 2×MOH;
Assess
PKA-S6K1 Chimera with Staurosporine bound
4c34
 Heteromer
Q3SX13; 		11-351
1×STU; 1×GOL; 1×MG8;
Assess
Protein kinase A fivefold mutant model of Rho-kinase
2gng
 Heteromer
P63248; 		11-351
Assess
The Catalytic Subunit of cAMP-dependent Protein Kinase (PKA) in Complex with Rho-kinase Inhibitor Y…
1q8t
 Heteromer
P61925; 		11-351
1×Y27;
Assess
Crystal Structure of Protein Kinase A in Complex with Azepane Derivative 4
1svg
 Heteromer
P61926; 		11-351
1×I04;
Assess
PKA five fold mutant model of Rho-kinase with H1152P
2gnh
 Heteromer
P61926; 		11-351
2×H52;
Assess
PKA-S6K1 Chimera with compound 1 (NU1085) bound
4c35
 Heteromer
Q3SX13; 		11-351
1×NU3; 1×MPD;
Assess
PKA fivefold mutant model of Rho-kinase with inhibitor Fasudil (HA1077)
2gni
 Heteromer
P61925; 		11-351
1×M77;
Assess
Protein kinase A fivefold mutant model of Rho-kinase with Y-27632
2gnf
 Heteromer
P63248; 		11-351
1×Y27;
Assess
Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu…
1xh7
 Heteromer
P61925; 		11-351
1×R96;
Assess
Crystal Structure of Protein Kinase A in Complex with Azepane Derivative 5
1veb
 Heteromer
P61925; 		11-351
1×I05;
Assess
The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors
3zo3
 Heteromer
Q3SX13; 		12-351
1×QNI; 7×MOH; 4×GOL;
Assess
PKA threefold mutant model of Rho-kinase with inhibitor H-1152P
2gnl
 Heteromer
P61926; 		12-351
1×H52;
Assess
Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu…
1xh8
 Heteromer
P61925; 		13-351
1×R55;
Assess
Structure of bovine PKA bound to (R)-N-(4-(1H-pyrrolo[2,3-b]pyridin-4-yl)phenyl)-2-amino-4-methylpe…
8sf8
 Heteromer
Q3SX13; 		13-351
1×ZWG;
Assess
Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu…
1xh9
 Heteromer
P61925; 		14-351
1×R69; 3×BU3;
Assess
PKA-S6K1 Chimera Apo
4c33
 Heteromer
Q3SX13; 		14-351
Assess
PKA-S6K1 Chimera with compound 21a (CCT196539) bound
4c37
 Heteromer
Q3SX13; 		14-351
1×Z21; 1×MPD;
Assess
Structure of PKA with a protein Kinase B-selective inhibitor.
3kkv
 Heteromer
14-351
1×B99;
Assess
Structure of PKA-PKB chimera complexed with 4-(4-Chlorobenzyl)-1-(7H- pyrrolo(2,3-d)pyrimidin-4-yl)…
2vo6
 Heteromer
P61925; 		14-351
1×CL; 1×M05;
Assess
PKA-S6K1 Chimera with compound 15e (CCT147581) bound
4c36
 Heteromer
Q3SX13; 		14-351
1×ZO9; 1×MOH;
Assess
cAMP-dependent protein kinase PKA catalytic subunit with PKI-5-24
3dne
 Heteromer
P61926; 		14-351
1×LL1;
Assess
PKA double mutant model of PKB
1q62
 Heteromer
P61925; 		14-351
Assess
PKAB3 in complex with pyrrolidine inhibitor 34a
4z84
 Heteromer
P61925; 		15-351
1×NVX; 2×MOH;
Assess
PKA-S6K1 Chimera with compound 21e (CCT239066) bound
4c38
 Heteromer
Q3SX13; 		15-351
1×VUP; 3×MOH;
Assess
The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors
3zo4
 Heteromer
Q3SX13; 		15-351
1×MPD; 1×QWI; 1×GOL; 1×DMS;
Assess
PKAB3 in complex with pyrrolidine inhibitor 47a
4z83
 Heteromer
P61925; 		15-351
2×4L7;
Assess
cAMP-dependent protein kinase PKA catalytic subunit with PKI-5-24
2gfc
 Heteromer
P61926; 		15-351
1×OCT;
Assess
Structure of PKA-PKB chimera complexed with (1S)-2-amino-1-(4- chlorophenyl)-1-(4-(1H-pyrazol-4-yl)…
4axa
 Heteromer
P61925; 		15-351
1×RKD;
Assess
Bovine PKA C-alpha in complex with 3-pyridylmethyl-5-methyl-1H-pyrazole-3-carboxylate
4ie9
 Heteromer
P61925; 		15-351
1×PZX; 1×GOL;
Assess
Structure of PKA-PKB chimera complexed with C-Phenyl-C-(4-(9H-purin-6- yl)-phenyl)-methylamine
2uvz
 Heteromer
P61925; 		15-351
1×GVJ;
Assess
Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based …
5vi9
 Heteromer
Q3SX13; 		15-351
1×9D4;
Assess
Structure of cAMP-dependent protein kinase complexed with Isoquinoline-5-sulfonic acid (2-(2-(4-chl…
2c1a
 Heteromer
P61925; 		15-351
1×I5S;
Assess
Structure of PKA-PKB chimera complexed with (1-(9H-Purin-6-yl) piperidin-4-yl)amine
2vny
 Heteromer
P61925; 		15-351
1×M02;
Assess
Structure of PKA complexed with 4-(4-Chlorobenzyl)-1-(7H-pyrrolo(2,3- d)pyrimidin-4-yl)piperidin-4-…
2vo7
 Heteromer
P61925; 		15-351
2×M05;
Assess
Structure of PKA-PKB chimera complexed with C-(4-(4-Chlorophenyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-y…
2vo3
 Heteromer
P61925; 		15-351
1×CL; 1×M04;
Assess
Structure of cAMP-dependent protein kinase complexed with A-443654
2jds
 Heteromer
P61925; 		15-351
1×L20;
Assess
Structure of PKA-PKB chimera complexed with 7-azaindole
2uvx
 Heteromer
P61925; 		15-351
1×GVH;
Assess
Structure of PKA-PKB chimera complexed with 2-(4-(5-methyl-1H-pyrazol- 4-yl)-phenyl)-ethylamine
2uw4
 Heteromer
P61925; 		15-351
1×L15;
Assess
Structure of cAMP-dependent protein kinase complexed with (4R,2S)-5'-(4-(4-Chlorobenzyloxy)pyrrolid…
2c1b
 Heteromer
P61925; 		15-351
1×CQP;
Assess
Structure of PKA-PKB chimera complexed with 2-(4-chloro-phenyl)-2- phenyl-ethylamine
2uw8
 Heteromer
P61925; 		15-351
1×GVQ;
Assess
Structure of PKA-PKB chimera complexed with 6-(4-(4-(4-Chloro-phenyl) -piperidin-4-yl)-phenyl)-9H-p…
2uw0
 Heteromer
P61925; 		15-351
1×GVK;
Assess
Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu…
1xh5
 Heteromer
P61925; 		15-351
1×R68; 3×BU3;
Assess
Structure of PKA-PKB chimera complexed with (1-(9H-Purin-6-yl) piperidin-4-yl)methanamine
2vnw
 Heteromer
P61925; 		15-351
1×M01;
Assess
Structure of PKA-PKB chimera complexed with 4-(4-chloro-phenyl)-4-(4- (1H-pyrazol-4-yl)-phenyl)-pip…
2uw7
 Heteromer
P61925; 		15-351
1×GVP;
Assess
PKA triple mutant model of PKB
1q61
 Heteromer
P61925; 		15-351
1×MG8;
Assess
CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24
4yxs
 Heteromer
P61926; 		15-351
1×EMU;
Assess
Structure of PKA-PKB chimera complexed with 5-methyl-4-phenyl-1H- pyrazole
2uw3
 Heteromer
P61925; 		15-351
1×GVG;
Assess
The Catalytic Subunit of cAMP-dependent Protein Kinase in Complex with Rho-kinase Inhibitor Fasudil…
1q8w
 Heteromer
P61926; 		15-351
1×M77;
Assess
Structure of PKA-PKB chimera complexed with (S)-2-(4-chloro-phenyl)- 2-(4-1H-pyrazol-4-yl)-phenyl)-…
2uw6
 Heteromer
P61925; 		15-351
1×GVO;
Assess
PKA three fold mutant model of Rho-kinase with Y-27632
2gnj
 Heteromer
Q3SX13; 		15-351
1×Y27;
Assess
Crystal Structure of Protein Kinase A in Complex with Azepane Derivative 8
1svh
 Heteromer
P63249; 		15-351
1×I08;
Assess
Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu…
1xh4
 Heteromer
P61925; 		15-351
1×R69;
Assess
Bovine PKA C-alpha in complex with 2-[[5-(4-pyridyl)-1H-1,2,4-triazol-3-yl]sulfanyl]-1-(2-thiopheny…
4ij9
 Heteromer
P61925; 		15-351
1×PTV;
Assess
PKA double mutant model of PKB in complex with MgATP
1q24
 Heteromer
Q71U53; 		15-351
1×MG; 1×ATP;
Assess
Protein Kinase A bound to (S)-2-(1H-Indol-3-yl)-1-[5-((E)-2-pyridin-4-yl-vinyl)-pyridin-3-yloxymeth…
2f7x
 Heteromer
Q71U53; 		16-351
1×4EA;
Assess
Structure of PKA-PKB chimera complexed with methyl-(4-(9H-purin-6-yl)- benzyl)-amine
2uvy
 Heteromer
P61925; 		16-351
1×GVI;
Assess
CRYSTAL STRUCTURE OF PKA IN COMPLEX WITH inhibitor.
4yxr
 Heteromer
Q3SX13; 		16-351
1×0RW;
Assess
PKA complexed with (S)-2-(1H-Indol-3-yl)-1-(5-isoquinolin-6-yl-pyridin-3-yloxymethyl-etylamine
2f7e
 Heteromer
P61925; 		16-351
1×2EA;
Assess
Structure of PKA-PKB chimera complexed with A-443654
2jdv
 Heteromer
P61925; 		16-351
1×L20;
Assess
Crystal structure of Protein Kinase A in complex with Pyridine-Pyrazolopyridine based inhibitors
2ojf
 Heteromer
16-351
1×4PY;
Assess
PKA structures of AKT, indazole-pyridine inhibitors
2uzt
 Heteromer
Q3SX13; 		16-351
1×SS3;
Assess
Structure of PKA-PKB chimera complexed with (R)-2-(4-chloro-phenyl)- 2-(4-1H-pyrazol-4-yl)-phenyl)-…
2uw5
 Heteromer
P61925; 		16-351
1×GVN;
Assess
Structure of PKA-PKB chimera complexed with ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) …
2jdt
 Heteromer
P61925; 		16-351
1×I5S;
Assess
Structure of CAMP-dependent protein kinase, alpha-catalytic subunit in complex with H8 protein kina…
1yds
 Heteromer
P63249; 		16-351
1×IQS;
Assess
Crystal structure of Protein Kinase A in complex with Pyridine-Pyrazolopyridine Based Inhibitors
2oh0
 Heteromer
16-351
1×2PY;
Assess
PKA structures of indazole-pyridine series of AKT inhibitors
2uzw
 Heteromer
Q3SX13; 		16-351
1×SS4;
Assess
STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H7 PROTEIN KINA…
1ydr
 Heteromer
P61925; 		16-351
1×IQP;
Assess
cAMP-dependent protein kinase PKA catalytic subunit with PKI-5-24
3dnd
 Heteromer
P61926; 		16-351
1×LL2;
Assess
CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH STAUROSPORINE
1stc
 Heteromer
P61926; 		16-351
1×STU;
Assess
STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H89 PROTEIN KIN…
1ydt
 Heteromer
P63249; 		16-351
1×IQB;
Assess
PKA structures of indazole-pyridine series of AKT inhibitors
2uzu
 Heteromer
Q3SX13; 		16-351
1×L20;
Assess
PKA structures of indazole-pyridine series of AKT inhibitors
2uzv
 Heteromer
Q3SX13; 		16-351
1×SS5;
Assess
Protein Kinase A bound to (R)-1-(1H-Indol-3-ylmethyl)-2-(2-pyridin-4-yl-[1,7]naphtyridin-5-yloxy)-e…
2f7z
 Heteromer
P61926; 		16-351
1×6EA;
Assess
Crystal structure of Protein Kinase A in complex with the PKI peptide and a pyridinylbenzamide base…
6e9l
 Heteromer
P61925; 		18-351
1×J0P;
Assess
Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based …
5vhb
 Heteromer
Q3SX13; 		19-351
1×9CY;
Assess
Crystal structure of Protein Kinase A in complex with the PKI peptide and an amino-pyridinylbenzami…
6e99
 Heteromer
P61925; 		19-351
1×J0G;
Assess
Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mu…
1xh6
 Heteromer
P61925; 		19-351
1×R94;
Assess
Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based …
5vib
 Heteromer
Q3SX13; 		19-351
1×9D1;
Assess
Complex of PKA with the bisubstrate protein kinase inhibitor lead compound Arc-1034
3bwj
monomer11-351
2×ARX;
Assess
Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1012
3ag9
monomer15-351
Assess
DUAL BINDING MODE OF BISINDOLYLMALEIMIDE 2 TO PROTEIN KINASE A (PKA)
1szm
monomer16-351
1×BI4;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2c1b.1.Amonomer0.9015-350
1×CQP;100.00
Assess
3k3i.1.Amonomer0.6241-335
25.27
Assess